Biomarkers in CardiologyBIC-2
- Conditions
- I20-I25Ischaemic heart diseases
- Registration Number
- DRKS00000309
- Lead Sponsor
- Charité - Universitätsmedizin Berlin Campus Virchow-Klinikum Medizinische Klinik m.S. Kardiologie Internistische Notaufnahme
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 532
Inclusion Criteria
Patient of full age, able to sign informed consent and was inpatient for elective PTCA
- Patient has frequented emergency room due to leading symptoms chest pain and/or dyspnea
Exclusion Criteria
- Redemption of consent
- Anemia < 10 g/dL
- Life expectancy < 6 months
- state of shock or acute disease patterrn
- age under 18 years
- Hospitalization according to official or judicial order
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The aim is the diagnostic and prognostic evaluation of biomarkers in cardiovascular diseases.<br>Primary endpoint for diagnosis is the main hospital diagnosis as documented in the final discharge letter (documentation in the eCRF)<br>Primary endpoint for prognosis is the 3 months mortality and re-hospitalization.
- Secondary Outcome Measures
Name Time Method